Vilacto Bio Stock

Vilacto Bio Equity

Delisted

The The Equity of Vilacto Bio (VIBI) as of Aug 14, 2026 is -3.42 M USD. In the previous year, The Equity was -935,914.00 USD — a change of 265.71% (lower).

Equity

-3.42 MUSD

YoY

265.71%

Last updated:

In 2026, Vilacto Bio's equity was -3.42 M USD, a 265.71% increase from the -935,914.00 USD equity in the previous year.

Access this data via the Eulerpool API

Vilacto Bio Stock analysis

What does Vilacto Bio do? Vilacto Bio Inc is a company that was founded in the USA in 2014. It was founded with the goal of producing natural and high-quality skincare products that support skin health and behave environmentally and ethically responsibly. The history of Vilacto Bio began when the CEO and founder of the company, Allan Villadsen, started his company with the production of concentrate products for cosmetics. The company was based on his research and discovery of a previously unknown ingredient, namely Lactoactive. This miracle substance could help in the treatment of skin conditions such as acne, psoriasis, and eczema. Vilacto Bio's products quickly experienced success and were praised by many customers and skincare experts worldwide. Vilacto Bio offers a variety of skincare products, including face creams, face masks, hand creams, body butter, body oils, and lip balms. The company uses only natural ingredients such as aloe vera, propolis, and shea butter to ensure that their products are as gentle as possible on the skin. Vilacto Bio's skincare products are divided into three different lines - Vilacto Premium Line, Vilacto Medi+ Line, and Vilacto Baby & Kids Line. Vilacto Premium Line is intended for people looking for high-quality and luxurious skincare products. Vilacto Medi+ Line is particularly suitable for people suffering from skin conditions such as psoriasis. Vilacto Baby & Kids Line, on the other hand, is suitable for the delicate and sensitive skin of children and babies. Vilacto Bio's business model is based on the principles of sustainability and ethical production. The company is committed to producing its products in an environmentally friendly manner and is committed to considering social and environmental conditions in every production. Vilacto Bio demonstrates this through careful selection of suppliers, raw materials, and packaging. The company's goal is to produce products that are not only good for the skin but also good for the environment and society as a whole. Overall, Vilacto Bio is a company dedicated to the production of natural and skin-friendly cosmetic products. They are passionate, committed, and strive to produce the best possible products for their customers. They believe in sustainability, ethical practices, and global responsibility, and demonstrate this in every aspect of their product manufacturing. Through their ability to combine natural skincare products with innovative formulas and sustainability, they are making a name for themselves as a leading skincare manufacturer worldwide. Vilacto Bio is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Vilacto Bio's Equity

Vilacto Bio's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Vilacto Bio's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Vilacto Bio's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Vilacto Bio's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Vilacto Bio’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Vilacto Bio stock

The Equity of Vilacto Bio is -3.42 M USD in 2026.

The Equity of Vilacto Bio changed from -935,914.00 USD to -3.42 M USD, representing a 265.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Vilacto Bio since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Vilacto Bio historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Vilacto Bio

All Key Metrics — Vilacto Bio